Runze Wang is currently working on the development of nanocarriers for alpha emitters which are suitable for alpha radionuclide therapy. He is now focusing on the design of a nanocarrier for the 212Pb/212Bi “in vivo generator”. The main challenge is to prevent the release of 212Bi from the carrier due to the internal conversion of 212Pb. He is also working on a radiobiological project about the influence of dose rate on the DNA damage induced by external irradiation using beta emitting radionuclides.
- 2017-2019 MSc in Chemical Engineering-Nuclear Science and Engineering, Delft University of Technology, the Netherlands.
- 2019-present PhD candidate, Faculty of Applied Science, Delft University of Technology, the Netherlands.